After collecting a de novo clearance from the FDA last fall for its ultrasound-powered liver cancer treatment, HistoSonics has raised $102 million in funds to turn up the volume on its commercial ...
Histotripsy treats hard-to-reach liver tumors using sound. The FDA cleared a new histotripsy device called Edison in October 2023. Doctors have begun treating liver tumors with a new knife-free ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min The FDA gave HistoSonics market ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results